Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior

BACKGROUND: Several second generation antipsychotics (SGAs) received FDA approval for bipolar disorder in the 2000s. Although efficacious, they have been costly and may cause significant side effects. Little is known about the factors associated with prescribers’ decisions to initiate SGA prescripti...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Christopher J, Li, Mingfei, Penfold, Robert B, Lee, Austin F, Smith, Eric G, Osser, David N, Bajor, Laura, Bauer, Mark S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256839/
https://www.ncbi.nlm.nih.gov/pubmed/25433807
http://dx.doi.org/10.1186/s12888-014-0339-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256839/
https://www.ncbi.nlm.nih.gov/pubmed/25433807
http://dx.doi.org/10.1186/s12888-014-0339-z

Ejemplares similares